Section Arrow
Quote
ALKS.NASDAQ
- Alkermes plc
Quotes are at least 15-min delayed:2026/06/28 00:06 EDT
Regular Hours
Last
 55.08
+2.25 (+4.26%)
Day High 
55.275 
Prev. Close
52.83 
1-M High
53.688 
Volume 
7.56M 
Bid
53.55
Ask
54.8
Day Low
52.385 
Open
52.87 
1-M Low
36.49 
Market Cap 
8.81B 
Currency 美元 
P/E 58.7 
%Yield -- 
10-SMA 46.45 
20-SMA 44.49 
50-SMA 39.07 
52-W High 53.688 
52-W Low 25.165 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.90/-0.39
Enterprise Value
8.87B
Balance Sheet
Book Value Per Share
10.51
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
1.48B
Operating Revenue Per Share
9.54
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc4.02+0.24+6.35%37.8PE
PRGOPerrigo Company PLC9.95+0.27+2.79%-- 
HIMSHims & Hers Health33.94+1.23+3.76%-- 
UPCUniverse Pharmaceuticals Inc2.96+0.12+4.23%-- 
ZTSZOETIS76.09-1.73-2.22%12.76PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.